
Marshall Wace’s SPDR S&P Biotech ETF XBI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $334K | Sell |
4,023
-20,971
| -84% | -$1.74M | ﹤0.01% | 2161 |
|
2025
Q1 | $2.03M | Buy |
24,994
+17,071
| +215% | +$1.38M | ﹤0.01% | 1371 |
|
2024
Q4 | $714K | Buy |
7,923
+2,600
| +49% | +$234K | ﹤0.01% | 1756 |
|
2024
Q3 | $526K | Sell |
5,323
-10,767
| -67% | -$1.06M | ﹤0.01% | 1763 |
|
2024
Q2 | $1.49M | Buy |
16,090
+13,290
| +475% | +$1.23M | ﹤0.01% | 1365 |
|
2024
Q1 | $266K | Sell |
2,800
-2,700
| -49% | -$256K | ﹤0.01% | 1892 |
|
2023
Q4 | $491K | Sell |
5,500
-3,719
| -40% | -$332K | ﹤0.01% | 1432 |
|
2023
Q3 | $673K | Sell |
9,219
-110,671
| -92% | -$8.08M | ﹤0.01% | 1368 |
|
2023
Q2 | $9.97M | Buy |
119,890
+19,770
| +20% | +$1.64M | 0.02% | 634 |
|
2023
Q1 | $7.63M | Buy |
+100,120
| New | +$7.63M | 0.02% | 699 |
|
2022
Q4 | – | Hold |
0
| – | – | – | 2891 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 3144 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 3232 |
|
2022
Q1 | – | Hold |
0
| – | – | – | 3401 |
|
2021
Q4 | – | Sell |
-34,960
| Closed | -$4.4M | – | 3630 |
|
2021
Q3 | $4.4M | Buy |
+34,960
| New | +$4.4M | 0.02% | 866 |
|
2021
Q2 | – | Sell |
-39,139
| Closed | -$5.31M | – | 2613 |
|
2021
Q1 | $5.31M | Buy |
+39,139
| New | +$5.31M | 0.02% | 725 |
|
2019
Q4 | – | Sell |
-10,967
| Closed | -$836K | – | 2061 |
|
2019
Q3 | $836K | Buy |
+10,967
| New | +$836K | 0.01% | 946 |
|
2018
Q4 | – | Sell |
-16,845
| Closed | -$1.62M | – | 1840 |
|
2018
Q3 | $1.62M | Buy |
+16,845
| New | +$1.62M | 0.01% | 719 |
|
2018
Q2 | – | Sell |
-136,825
| Closed | -$12M | – | 854 |
|
2018
Q1 | $12M | Sell |
136,825
-79,098
| -37% | -$6.94M | 0.5% | 59 |
|
2017
Q4 | $18.3M | Buy |
+215,923
| New | +$18.3M | 0.77% | 31 |
|
2017
Q2 | – | Sell |
-79,271
| Closed | -$5.47M | – | 396 |
|
2017
Q1 | $5.47M | Buy |
+79,271
| New | +$5.47M | 0.26% | 85 |
|